GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (ASX:MSB) » Definitions » Short Ratio

Mesoblast (ASX:MSB) Short Ratio


View and export this data going back to 2004. Start your Free Trial

What is Mesoblast Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Mesoblast (ASX:MSB) Business Description

Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Mesoblast (ASX:MSB) Headlines

From GuruFocus

Mesabi Trust Press Release

By Business Wire Business Wire 10-14-2022

Murray Stahl Digs Deeper Into Mesabi Trust

By Sydnee Gatewood Sydnee Gatewood 12-09-2020

Mesabi Trust Press Release

By Business Wire Business Wire 04-15-2022

Mesabi Trust Press Release

By Business Wire Business Wire 07-12-2021

Mesabi Trust Press Release

By Business Wire Business Wire 05-03-2022

Mesabi Trust Stock Appears To Be Significantly Overvalued

By GF Value GF Value 04-30-2021

Mesabi Trust Press Release

By Business Wire 01-12-2024